You are here: Home: Meet The Professors Vol. 3 Issue 4 2005: Case 4

Case 4: A 66-year-old woman who was diagnosed with lobular carcinoma at age 59 and progressive metastatic disease to the cervical spine one year later, with anemia, bone marrow invasion and skin nodules. The patient experienced a complete clinical remission for approximately 3.5 years while on tamoxifen with subsequent recurrence of bony metastases, skin lesions and pancytopenia (from the practice of Dr Michael A Harris)
 

Cristofanilli M et al. Invasive lobular carcinoma classic type: Response to primary chemotherapy and survival outcomes. J Clin Oncol 2005;23(1):41-8. Abstract

Howell A et al. Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: A multinational, double-blind, randomized trial. J Clin Oncol 2004;22(9):1605-13. Abstract

Mauriac L et al. Fulvestrant (Faslodex) versus anastrozole for the second-line
treatment of advanced breast cancer in subgroups of postmenopausal women with
visceral and non-visceral metastases: Combined results from two multicentre
trials. Eur J Cancer 2003;39(9):1228-33. Abstract

 

 

 

 

Table of Contents
 
Home · Contact Us
Terms of Use and General Disclaimer
Copyright © 2005 Research To Practice. All Rights Reserved